Mounjaro, Weight loss

Patients self-administer the drug using a pre-dosed injector pen, but Lilly recently introduced the product in single-dose ...
Mounjaro is a treatment for Type 2 diabetes that activates GIP and GLP-1 pathways to help regulate blood sugar. It’s part of ...
The NHS could start administering a new weight-loss injection as early as March 2025, but eligible patients may have to ...
The rollout of the weight-loss drug to 3.4 million eligible patients could take up to 12 years, according to NICE.